Chemotherapy-induced Peripheral Neuropathy (CIPN)

Also known as: Chemotherapy-Induced Peripheral Neuropathy

DrugDrug NameDrug Description
DB00476DuloxetineDuloxetine is a dual serotonin and norepinephrine reuptake inhibitor.[label] It was originally discovered in 1993 and developed by Eli Lilly and Company as LY248686.[A178741] Duloxetine first received approval from the FDA in August, 2004 as Cymbalta for the treatment of Major Depressive Disorder.[L6454] It has since received approval for a variety of indications including the treatment of neuropathic pain, Generalized Anxiety disorder, osteoarthritis, and stress incontinence. Duloxetine continues to be investigated for the treatment of pain in cancer, surgery, and more.
DrugDrug NamePhaseStatusCount
DB08868Fingolimod0Recruiting1
DB00281Lidocaine1 / 2Recruiting1
DB11121Chloroxylenol2Completed1
DB11121Chloroxylenol2Not Yet Recruiting1
DB00514Dextromethorphan2Recruiting1
DB04871Lorcaserin2Not Yet Recruiting1
DB14933Nicotinamide riboside2Recruiting1
DB05185TRO196222Completed1
DB00230Pregabalin4Terminated1